← Leaderboards
Judith A James
Oklahoma Medical Research Foundation
$55,525,870
Attributed
$67,382,645
Total exposure
47
Grants
38
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $18M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$155,944,121 · 53
By mechanism
U54$72,158,575 · 6
P30$22,097,786 · 10
UC2$19,601,747 · 1
U19$15,539,381 · 10
P20$7,946,455 · 10
U01$6,135,852 · 2
Top collaborators
- Joel Marvin Guthridge8 shared
- Jeffrey C Rathmell3 shared
- V Michael Holers2 shared
Most similar at Oklahoma Medical Research Foundation
Same institution · by research overlap
- Kenneth Mark Coggeshall$14,637,824
- A. Darise Farris$16,682,449
- Neelakshi Ramchandra Jog$174,800
Others in their field
Top investigators on “Oklahoma”
- Darrin R Akins · University Of Oklahoma Hlth Sciences Ctr$34,195,521
- Gary L White · University Of Oklahoma Hlth Sciences Ctr$19,506,526
- Elisa Lee · University Of Oklahoma Hlth Sciences Ctr$19,212,008
- Barbara V Howard · Medlantic Research Institute$14,997,591
- F Daniel Duffy · University Of Oklahoma Hlth Sciences Ctr$14,977,883
- Barry M. Lester · Emma Pendleton Bradley Hospital$14,522,444
Research focus
OklahomaResearch PersonnelResourcesAutoimmunityProgramsFundingSamplingClinical ResearchFoundationsLeadershipSystemic Lupus ErythematosusServicesCollaborationsBaseInstitutionCollectionGrantMissionAutoimmune DiseasesClinical TrialsImmuneScientistUnited States National Institutes Of HealthLupus
Grant awards (197)
Oklahoma Shared Clinical and Translational Resources$4,357,718
U54 · FY2025 · GM · contact PI
Autoimmune Drivers and Protectors Team Science (ADAPTS)$1,249,430
U01 · FY2025 · AI · contact PI
Administrative Core$1,075,611
U54 · FY2025 · GM · contact PI
Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail Success$767,250
UM1 · FY2025 · AI · contact PI
Oklahoma Rheumatic Disease Research Cores Center$767,249
P30 · FY2025 · AR · contact PI
Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core$500,001
UC2 · FY2025 · AR
Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail Success$400,579
UM1 · FY2025 · AI · contact PI
Environmental Influences Driving Autoimmunity and Autoimmune Disease in Tribal Members$375,258
S06 · FY2025 · GM · contact PI
Administrative Core$255,750
P30 · FY2025 · AR · contact PI
Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core$1
UC2 · FY2025 · AR
Oklahoma Shared Clinical and Translational Resources$3,999,999
U54 · FY2024 · GM · contact PI
Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core$3,700,000
UC2 · FY2024 · AR
Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core$1,460,414
UC2 · FY2024 · AR
Autoimmune Drivers and Protectors Team Science (ADAPTS)$1,288,071
U01 · FY2024 · AI · contact PI
Oklahoma Rheumatic Disease Research Cores Center$852,500
P30 · FY2024 · AR · contact PI
Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail Success$767,250
UM1 · FY2024 · AI · contact PI
Administrative Core$717,892
U54 · FY2024 · GM · contact PI
Environmental Influences Driving Autoimmunity and Autoimmune Disease in Tribal Members$375,370
S06 · FY2024 · GM · contact PI
Administrative Core$358,813
U54 · FY2024 · GM · contact PI
Oklahoma Shared Clinical and Translational Resources$358,813
U54 · FY2024 · GM · contact PI
Administrative Core$170,500
P30 · FY2024 · AR · contact PI
Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core$7,289,569
UC2 · FY2023 · AR
Oklahoma Shared Clinical and Translational Resources$4,299,999
U54 · FY2023 · GM · contact PI
Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core Admin Supplement: Preclinical Studies in Sjogren's$1,460,414
UC2 · FY2023 · AR
Autoimmune Drivers and Protectors Team Science (ADAPTS)$1,323,321
U01 · FY2023 · AI · contact PI
Oklahoma Rheumatic Disease Research Cores Center$852,500
P30 · FY2023 · AR · contact PI
Administrative Core$708,360
U54 · FY2023 · GM · contact PI
Mechanisms of Humoral Immune Protection Induced by Anthrax Vaccine Adsorbed$457,274
U19 · FY2023 · AI · contact PI
Environmental Influences Driving Autoimmunity and Autoimmune Disease in Tribal Members$375,370
S06 · FY2023 · GM · contact PI
Oklahoma Shared Clinical and Translational Resources$354,567
U54 · FY2023 · GM · contact PI
Oklahoma Shared Clinical and Translational Resources$304,702
U54 · FY2023 · GM · contact PI
Alterations and Renovations$300,000
U54 · FY2023 · GM · contact PI
Administrative Core$170,500
P30 · FY2023 · AR · contact PI
Oklahoma ACE: Molecular Deconstruction of Autoimmune Disease to Aid Clinical Trial Success$87,400
UM1 · FY2023 · AI · contact PI
Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core$5,050,000
UC2 · FY2022 · AR
Oklahoma Shared Clinical and Translational Resources$3,930,606
U54 · FY2022 · GM · contact PI
Oklahoma Rheumatic Disease Research Cores Center (Overall Application)$874,000
P30 · FY2022 · AR · contact PI
Administrative Core$774,962
U54 · FY2022 · GM · contact PI
Mechanisms of Humoral Immune Protection Induced by Anthrax Vaccine Adsorbed$494,757
U19 · FY2022 · AI · contact PI
Environmental Influences Driving Autoimmunity and Autoimmune Disease in Tribal Members$372,113
S06 · FY2022 · GM · contact PI
Administrative Core$198,815
P30 · FY2022 · AR · contact PI
Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core$141,348
UC2 · FY2022 · AR
Oklahoma ACE: Molecular Deconstruction of Autoimmune Disease to Aid Clinical Trial Success$87,400
UM1 · FY2022 · AI · contact PI
Oklahoma Shared Clinical and Translational Resources$37,500
U54 · FY2022 · GM · contact PI
Oklahoma Shared Clinical and Translational Resources$3,852,339
U54 · FY2021 · GM · contact PI
Oklahoma Shared Clinical and Translational Resources$1,759,106
U54 · FY2021 · GM · contact PI
Oklahoma Rheumatic Disease Research Cores Center (Overall Application)$874,000
P30 · FY2021 · AR · contact PI
Oklahoma Shared Clinical and Translational Resources$873,916
U54 · FY2021 · GM · contact PI
Administrative Core$763,385
U54 · FY2021 · GM · contact PI
Mechanisms of Humoral Immune Protection Induced by Anthrax Vaccine Adsorbed$458,416
U19 · FY2021 · AI · contact PI
Molecular Phenotyping of Autoimmunity in Tribal Members: Aiding Precision Medicine and Tribal Student Training$373,899
S06 · FY2021 · GM · contact PI
Oklahoma PREVENT: PRogram to Enhance Vaccine Equity in Non-metropolitan and Tribal areas$305,815
U54 · FY2021 · GM · contact PI
CATCH-UP Vaccines$262,500
U54 · FY2021 · GM · contact PI
Administrative Core$198,815
P30 · FY2021 · AR · contact PI
Oklahoma ACE: Molecular Deconstruction of Autoimmune Disease to Aid Clinical Trial Success$87,400
UM1 · FY2021 · AI · contact PI
Oklahoma Shared Clinical and Translational Resources$3,936,058
U54 · FY2020 · GM · contact PI
Oklahoma Shared Clinical and Translational Resources$3,240,887
U54 · FY2020 · GM · contact PI
Oklahoma Rheumatic Disease Research Cores Center (Overall Application)$874,000
P30 · FY2020 · AR · contact PI
Administrative Core$774,962
U54 · FY2020 · GM · contact PI
Mechanisms of Humoral Immune Protection Induced by Anthrax Vaccine Adsorbed$463,182
U19 · FY2020 · AI · contact PI
Mechanisms of Lupus Disease Transition and Hydroxychloroquine Immune Modulation$460,680
R01 · FY2020 · AR · contact PI
Molecular Phenotyping of Autoimmunity in Tribal Members: Aiding Precision Medicine and Tribal Student Training$391,006
S06 · FY2020 · GM · contact PI
Administrative Core$198,815
P30 · FY2020 · AR · contact PI
Oklahoma ACE: Molecular Deconstruction of Autoimmune Disease to Aid Clinical Trial Success$87,400
UM1 · FY2020 · AI · contact PI
Oklahoma Shared Clinical and Translational Resources$3,938,665
U54 · FY2019 · GM · contact PI
Oklahoma Rheumatic Disease Research Cores Center (Overall Application)$874,000
P30 · FY2019 · AR · contact PI
Administrative Core$774,961
U54 · FY2019 · GM · contact PI
Mechanisms of Humoral Immune Protection Induced by Anthrax Vaccine Adsorbed$480,349
U19 · FY2019 · AI · contact PI
Mechanisms of Lupus Disease Transition and Hydroxychloroquine Immune Modulation$460,680
R01 · FY2019 · AR · contact PI
Molecular Phenotyping of Autoimmunity in Tribal Members: Aiding Precision Medicine and Tribal Student Training$391,006
S06 · FY2019 · GM · contact PI
Oklahoma ACE: Molecular Deconstruction of Autoimmune Disease to Aid Clinical Trial Success$262,200
UM1 · FY2019 · AI · contact PI
Administrative Core$198,815
P30 · FY2019 · AR · contact PI
Oklahoma Shared Clinical and Translational Resources$4,046,492
U54 · FY2018 · GM · contact PI
Oklahoma Rheumatic Disease Research Cores Center (Overall Application)$874,000
P30 · FY2018 · AR · contact PI
Oklahoma Autoimmunity Center of Excellence Mechanisms of Disease Flare$819,413
U19 · FY2018 · AI · contact PI
Administrative Core$797,077
U54 · FY2018 · GM · contact PI
Mechanisms of Lupus Disease Transition and Hydroxychloroquine Immune Modulation$460,680
R01 · FY2018 · AR · contact PI
Mechanisms of Disease Flare in SLE$455,222
U19 · FY2018 · AI · contact PI
Molecular Phenotyping of Autoimmunity in Tribal Members: Aiding Precision Medicine and Tribal Student Training$381,517
S06 · FY2018 · GM · contact PI
Administrative Core$198,551
P30 · FY2018 · AR · contact PI
Administrative Core$71,820
U19 · FY2018 · AI · contact PI
Oklahoma Shared Clinical and Translational Resources$4,000,000
U54 · FY2017 · GM · contact PI
Oversight and Management Core$928,174
U54 · FY2017 · GM · contact PI
Oklahoma Rheumatic Disease Research Cores Center$672,000
P30 · FY2017 · AR · contact PI
Mechanisms of Lupus Disease Transition and Hydroxychloroquine Immune Modulation$460,680
R01 · FY2017 · AR · contact PI
Oklahoma Autoimmunity Center of Excellence Mechanisms of Disease Flare$459,405
U19 · FY2017 · AI · contact PI
Mechanisms of Disease Flare in SLE$85,574
U19 · FY2017 · AI · contact PI
Administrative Core$73,721
U19 · FY2017 · AI · contact PI
Oklahoma Shared Clinical and Translational Resources$4,000,000
U54 · FY2016 · GM · contact PI
Oversight and Management Core$928,174
U54 · FY2016 · GM · contact PI
Oklahoma Rheumatic Disease Research Cores Center$672,000
P30 · FY2016 · AR · contact PI
Oklahoma Autoimmunity Center of Excellence Mechanisms of Disease Flare$459,405
U19 · FY2016 · AI · contact PI
Understanding early events in lupus autoimmunity to aid prevention$409,236
U01 · FY2016 · AI · contact PI
Science in a Culture of Mentoring$328,037
P30 · FY2016 · GM · contact PI
Mechanisms of Disease Flare in SLE$84,334
U19 · FY2016 · AI · contact PI
Administrative Core$79,310
U19 · FY2016 · AI · contact PI
Oklahoma Shared Clinical and Translational Resources$4,000,000
U54 · FY2015 · GM · contact PI
Oversight and Management Core$928,174
U54 · FY2015 · GM · contact PI
Oklahoma Rheumatic Disease Research Cores Center$672,000
P30 · FY2015 · AR · contact PI
Oklahoma Autoimmunity Center of Excellence Mechanisms of Disease Flare$459,405
U19 · FY2015 · AI · contact PI
Understanding early events in lupus autoimmunity to aid prevention$409,236
U01 · FY2015 · AI · contact PI
Mechanisms of Disease Flare in SLE$85,000
U19 · FY2015 · AI · contact PI
Tissue Acquisition Research Group$80,316
UM2 · FY2015 · AR · contact PI
Administrative Core$78,644
U19 · FY2015 · AI · contact PI
Oklahoma Shared Clinical and Translational Resources$4,000,000
U54 · FY2014 · GM · contact PI
Science in a Culture of Mentoring$1,223,569
P30 · FY2014 · GM · contact PI
Oversight and Management Core$928,174
U54 · FY2014 · GM · contact PI
Oklahoma Rheumatic Disease Research Cores Center$672,000
P30 · FY2014 · AR · contact PI
Understanding early events in lupus autoimmunity to aid prevention$656,153
U01 · FY2014 · AI · contact PI
Oklahoma Autoimmunity Center of Excellence Mechanisms of Disease Flare$544,404
U19 · FY2014 · AI · contact PI
Tissue Acquisition Research Group$170,666
UM2 · FY2014 · AR · contact PI
Mechanisms of Disease Flare in SLE$85,000
U19 · FY2014 · AI · contact PI
Administrative Core$76,904
U19 · FY2014 · AI · contact PI
Oklahoma Shared Clinical and Translational Resources$4,300,000
U54 · FY2013 · GM · contact PI
Science in a Culture of Mentoring$1,180,744
P30 · FY2013 · GM · contact PI
Oversight and Management Core$940,174
U54 · FY2013 · GM · contact PI
Oklahoma Autoimmunity Center of Excellence$640,939
U19 · FY2013 · AI · contact PI
Oklahoma Rheumatic Disease Research Cores Center$638,400
P30 · FY2013 · AR · contact PI
Characterization of Protective Humoral Anthrax Immunity$477,330
U19 · FY2013 · AI · contact PI
Understanding early events in lupus autoimmunity to aid prevention$384,680
U01 · FY2013 · AI · contact PI
Alterations and Renovations$300,000
U54 · FY2013 · GM · contact PI
Pre-Clinical Studies to Identify SLE Therapeutic Targets$256,511
U19 · FY2013 · AI · contact PI
Administrative Core$127,918
U19 · FY2013 · AI · contact PI
Science in a Culture of Mentoring$1,179,870
P30 · FY2012 · GM · contact PI
Oklahoma Autoimmunity Center of Excellence$682,136
U19 · FY2012 · AI · contact PI
Oklahoma Rheumatic Disease Research Cores Center$672,000
P30 · FY2012 · AR · contact PI
Understanding early events in lupus autoimmunity to aid prevention$415,725
U01 · FY2012 · AI · contact PI
Characterization of Protective Humoral Anthrax Immunity$340,119
U19 · FY2012 · AI · contact PI
Pre-Clinical Studies to Identify SLE Therapeutic Targets$276,909
U19 · FY2012 · AI · contact PI
Administrative Core$128,324
U19 · FY2012 · AI · contact PI
Science in a Culture of Mentoring$1,177,136
P30 · FY2011 · RR · contact PI
Oklahoma Autoimmunity Center of Excellence$696,347
U19 · FY2011 · AI · contact PI
Oklahoma Rheumatic Disease Research Core Centers$560,720
P30 · FY2011 · AR · contact PI
Characterization of Protective Humoral Anthrax Immunity$328,544
U19 · FY2011 · AI · contact PI
Pre-Clinical Studies to Identify SLE Therapeutic Targets$281,666
U19 · FY2011 · AI · contact PI
CORE C: CLINICAL CORE$195,228
P30 · FY2011 · RR · contact PI
CORE A: ADMINISTRATIVE$172,722
P30 · FY2011 · RR · contact PI
Administrative Core$133,019
U19 · FY2011 · AI · contact PI
Science in a Culture of Mentoring$1,189,027
P30 · FY2010 · RR · contact PI
Oklahoma Autoimmunity Center of Excellence$712,620
U19 · FY2010 · AI · contact PI
Oklahoma Rheumatic Disease Research Core Centers$560,720
P30 · FY2010 · AR · contact PI
Predicting Systemic Autoimmunity through Follow-up of Blood Relatives$499,740
RC1 · FY2010 · AR · contact PI
Characterization of Protective Humoral Anthrax Immunity$345,989
U19 · FY2010 · AI · contact PI
Oklahoma High-Throughput Serum Analyte System$311,251
S10 · FY2010 · RR · contact PI
Pre-Clinical Studies to Identify SLE Therapeutic Targets$288,249
U19 · FY2010 · AI · contact PI
Administrative Core$136,126
U19 · FY2010 · AI · contact PI
Science in a Culture of Mentoring$1,846,823
P20 · FY2009 · RR · contact PI
Oklahoma Autoimmunity Center of Excellence$702,688
U19 · FY2009 · AI · contact PI
Oklahoma Rheumatic Disease Research Core Centers$560,720
P30 · FY2009 · AR · contact PI
Predicting Systemic Autoimmunity through Follow-up of Blood Relatives$500,000
RC1 · FY2009 · AR · contact PI
Science in a Culture of Mentoring$499,999
P20 · FY2009 · RR · contact PI
Characterization of Protective Humoral Anthrax Immunity$343,438
U19 · FY2009 · AI · contact PI
Science in a Culture of Mentoring$300,000
P20 · FY2009 · RR · contact PI
Pre-Clinical Studies to Identify SLE Therapeutic Targets$284,230
U19 · FY2009 · AI · contact PI
ADMINISTRATIVE CORE$221,102
P20 · FY2009 · RR · contact PI
Administrative Core$134,230
U19 · FY2009 · AI · contact PI
PILOT PROJECT$106,488
P20 · FY2009 · RR · contact PI
Science in a Culture of Mentoring$1,820,108
P20 · FY2008 · RR · contact PI
Oklahoma Rheumatic Disease Research Core Centers$533,200
P30 · FY2008 · AR · contact PI
Characterization of Protective Humoral Anthrax Immunity$367,913
U19 · FY2008 · AI · contact PI
ADMINISTRATIVE CORE$215,974
P20 · FY2008 · RR · contact PI
PILOT PROJECT$203,452
P20 · FY2008 · RR · contact PI
RECRUITING CORE$131,448
P20 · FY2008 · RR · contact PI
Administrative Core$74,399
P30 · FY2008 · AR · contact PI
Science in a Culture of Mentoring$1,802,730
P20 · FY2007 · RR · contact PI
Oklahoma Rheumatic Disease Research Core Centers$533,200
P30 · FY2007 · AR · contact PI
Characterization of Protective Humoral Anthrax Immunity$429,638
U19 · FY2007 · AI · contact PI
Administrative Core$197,284
P30 · FY2007 · AR · contact PI
CORE: PEPTIDE SYNTHESIS CORE FACILITY$72,090
P20 · FY2007 · RR · contact PI
Characterization of Protective Humoral Anthrax Immunity$382,417
U19 · FY2006 · AI · contact PI
CORE: PEPTIDE SYNTHESIS CORE FACILITY$74,263
P20 · FY2006 · RR · contact PI
Characterization of Protective Humoral Anthrax Immunity$382,404
U19 · FY2005 · AI
Fine specificity of scleroderma autoantibodies$313,800
R01 · FY2005 · AR
COBRE: CORE4: PEPTIDE SYNTHESIS CORE FACILITY$58,950
P20 · FY2005 · RR
Characterization of Protective Humoral Anthrax Immunity$388,138
U19 · FY2004 · AI
Fine specificity of scleroderma autoantibodies$313,800
R01 · FY2004 · AR
GENETIC ANALYSIS OF EPITOPE SPREADING$109,314
R01 · FY2004 · AR
COBRE: CORE4: PEPTIDE SYNTHESIS CORE FACILITY$80,870
P20 · FY2004 · RR
Early Splicesomal Peptide Epitopes in Lupus$754
M01 · FY2004 · RR
Fine specificity of scleroderma autoantibodies$313,800
R01 · FY2003 · AR
ROLE OF ANTI-PROTEINASE-3 IN WEGENER'S VASCULOPATHY$290,700
R01 · FY2003 · AI
GENETIC ANALYSIS OF EPITOPE SPREADING$106,132
R01 · FY2003 · AR
Fine specificity of scleroderma autoantibodies$313,800
R01 · FY2002 · AR
ROLE OF ANTI-PROTEINASE-3 IN WEGENER'S VASCULOPATHY$261,630
R01 · FY2002 · AI
GENETIC ANALYSIS OF EPITOPE SPREADING$103,038
R01 · FY2002 · AR
Core--Peptide synthesis facility$0
P20 · FY2002 · RR
DEVELOPMENT OF ANTI-nRNP AUTOANTIBODIES$0
P50 · FY2002 · AR
Fine specificity of scleroderma autoantibodies$313,800
R01 · FY2001 · AR
ROLE OF ANTI-PROTEINASE-3 IN WEGENER'S VASCULOPATHY$290,700
R01 · FY2001 · AI
Core--Peptide synthesis facility$256,079
P20 · FY2001 · RR
GENETIC ANALYSIS OF EPITOPE SPREADING$117,740
R01 · FY2001 · AR
Core--Peptide synthesis facility$0
P20 · FY2001 · RR
ROLE OF ANTI-PROTEINASE-3 IN WEGENER'S VASCULOPATHY$340,700
R01 · FY2000 · AI
Core--Peptide synthesis facility$256,079
P20 · FY2000 · RR
GENETIC ANALYSIS OF LUPUS AUTOIMMUNITY$122,040
K08 · FY2000 · AR
GENETIC ANALYSIS OF EPITOPE SPREADING$115,718
R01 · FY2000 · AR
GENETIC ANALYSIS OF EPITOPE SPREADING$49,748
R01 · FY2000 · AR